|
|
|
| New Drug Delivery System: Delivery of Exosomes as Drug Carriers |
WU You,XIN Lin( ) |
| Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, China |
|
|
|
Abstract Exosomes are the substance that are released by most types of cells and have an important role in cell to cell communication. They also have great potential as a medicine delivery carrier, especially suitable for delivery of therapeutic drugs, such as proteins, nucleic acids and gene therapeutic agents due to the inherent long-distance communication capacity and excellent biocompatibility. Many studies show that exosome can efficiently deliver many different kinds of cargo to the target cell. Therefore, they are often used to deliver therapeutic cargo for treatment. As a result, the literature will introduce the advances and challenge facing exosomes as drug delivery systems, such as exosome isolation, drug loading and targeting therapy application, with the expectation of better delivering new ideas for the development of exosomal drug delivery systems.
|
|
Received: 14 May 2020
Published: 12 October 2020
|
|
|
|
Corresponding Authors:
Lin XIN
E-mail: xlyxbs@126.com
|
|
|
| [1] |
Ren L, Chen S, Li H, et al. MRI-guided liposomes for targeted tandem chemotherapy and therapeutic response prediction. Acta Biomaterialia, 2016,35:260-268.
pmid: 26873364
|
|
|
| [2] |
Masood F. Polymeric nanoparticles for targeted drug delivery system for cancer therapy. Materials Science and Engineering: C, 2016,60:569-578.
|
|
|
| [3] |
Riley R S, Day E S. Gold nanoparticle-mediated photothermal therapy: applications and opportunities for multimodal cancer treatment. Nanomedicine and Nanobiotechnology, 2017,9(4):1449.
|
|
|
| [4] |
Gurunathan S, Kang M H, Jeyaraj M, et al. Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes. Cells, 2019,8(4):307.
|
|
|
| [5] |
Lotvall J, Valadi H. Cell to cell signalling via exosomes through esRNA. Cell Adhesion & Migration, 2007,1(3):156-158.
doi: 10.4161/cam.1.3.5114
pmid: 19262134
|
|
|
| [6] |
Minciacchi V R, Freeman M R, Di Vizio D. Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes. Seminars in Cell & Developmental Biology, 2015,40:41-51.
pmid: 25721812
|
|
|
| [7] |
Khalyfa A, Gozal D. Exosomal miRNAs as potential biomarkers of cardiovascular risk in children. Journal of Translational Medicine, 2014,12:162.
doi: 10.1186/1479-5876-12-162
pmid: 24912806
|
|
|
| [8] |
Kamerkar S, LeBleu V S, Sugimoto H, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature, 2017,546(7659):498-503.
|
|
|
| [9] |
Takuma Y, Yuki T, Yoshinobu T. Possibility of exosome-based therapeutics and challenges in production of exosomes eligible for therapeutic application. Biological and Pharmaceutical Bulletin, 2018,41(6):835-842.
pmid: 29863072
|
|
|
| [10] |
Théry C, Amigorena S, Raposo G, et al. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Current Protocols in Cell Biology, 2006,3(1):22-29.
|
|
|
| [11] |
Shao H, Im H, Castro C M, et al. New technologies for analysis of extracellular vesicles. Chemical Reviews, 2018,118(4):1917-1950.
|
|
|
| [12] |
Taylor D D, Shah S. Methods of isolating extracellular vesicles impact down-stream analyses of their cargoes. Methods, 2015,87:3-10.
|
|
|
| [13] |
Emily Z, Timothy B, Li M, et al. Strategies for isolation of exosomes. [2020-06-07]. http://cshprotocols.cshlp.org/content/2015/4/pdb.top074476.long.htm.
|
|
|
| [14] |
Alvarez M L, Khosroheidari M, Kanchi Ravi R, et al. Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers. Kidney International, 2012,82(9):1024-1032.
pmid: 22785172
|
|
|
| [15] |
Laurent M, Hong C S, Db S, et al. Isolation of biologically-active exosomes from human plasma. Journal of Immunological Methods, 2014,411:55-65.
pmid: 24952243
|
|
|
| [16] |
Vaswani K, Mitchell M D, Holland O J, et al. A method for the isolation of exosomes from human and bovine milk. [2020-06-07]. https://www.hindawi.com/journals/jnme/2019/5764740/.htm.
|
|
|
| [17] |
Greening D W, Xu R, Ji H, et al. A protocol for exosome isolation and characterization: evaluation of ultracentrifugation, density-gradient separation, and immunoaffinity capture methods. Proteomic Profiling, 2015,1295:179-209.
|
|
|
| [18] |
Wu M, Ouyang Y, Wang Z, et al. Isolation of exosomes from whole blood by integrating acoustics and microfluidics. Proceedings of the National Academy of Sciences of the United States of America, 2017,114(40):10584-10589.
|
|
|
| [19] |
Liu C, Guo J, Tian F, et al. Field-free isolation of exosomes from extracellular vesicles by microfluidic viscoelastic flows. Acs Nano, 2017,11(7):6968-6976.
doi: 10.1021/acsnano.7b02277
pmid: 28679045
|
|
|
| [20] |
Lewis G D, Metcalf T G. Polyethylene glycol precipitation for recovery of pathogenic viruses, including hepatitis A virus and human rotavirus, from oyster, water, and sediment samples. Applied and Environmental Microbiology, 1988,54(8):1983-1988.
|
|
|
| [21] |
Martins T S, Catita J, Rosa I M, et al. Exosome isolation from distinct biofluids using precipitation and column-based approaches. PLoS One, 2018,13(6):e0198820.
|
|
|
| [22] |
Lane R E, Korbie D, Trau M, et al. Purification protocols for extracellular vesicles. Extracellular Vesicles Methods and Protocols, 2017,1660:111-130.
|
|
|
| [23] |
Brow T J, David G W, Ra M, et al. Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. Methods, 2012,56(2):293-304.
doi: 10.1016/j.ymeth.2012.01.002
pmid: 22285593
|
|
|
| [24] |
Chen B Y, Sung C W H, Chen C, et al. Advances in exosomes technology. Clinica Chimica Acta, 2019,493:14-19.
|
|
|
| [25] |
Chen C, Lin B R, Hsu M Y, et al. Paper-based devices for isolation and characterization of extracellular vesicles. Journal of Visualized Experiments, 2015, (98):52722.
|
|
|
| [26] |
Sun D, Zhuang X, Xiang X, et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Molecular Therapy, 2010,18(9):1606-1614.
pmid: 20571541
|
|
|
| [27] |
Agrawal A K, Aqil F, Jeyabalan J, et al. Milk-derived exosomes for oral delivery of paclitaxel. Nanomedicine: Nanotechnology, Biology, And Medicine, 2017,13(5):1627-1636.
|
|
|
| [28] |
Alvarez-Erviti L, Seow Y, Yin H, et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nature Biotechnology, 2011,29(4):341-345.
pmid: 21423189
|
|
|
| [29] |
Hood J L, Scott M J, Wickline S A. Maximizing exosome colloidal stability following electroporation. Analytical Biochemistry, 2014,448:41-49.
doi: 10.1016/j.ab.2013.12.001
pmid: 24333249
|
|
|
| [30] |
Lamichhane T N, Raiker R S, Jay S M. Exogenous DNA loading into extracellular vesicles via electroporation is size-dependent and enables limited gene delivery. Molecular Pharmaceutics, 2015,12(10):3650-3657.
doi: 10.1021/acs.molpharmaceut.5b00364
pmid: 26376343
|
|
|
| [31] |
Kooijmans S A A, Stremersch S, Braeckmans K, et al. Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles. Journal of Controlled Release, 2013,172(1):229-238.
doi: 10.1016/j.jconrel.2013.08.014
pmid: 23994516
|
|
|
| [32] |
Shtam T A, Kovalev R A, Varfolomeeva E Y, et al. Exosomes are natural carriers of exogenous siRNA to human cells in vitro. Cell Communication and Signaling, 2013,11:88.
doi: 10.1186/1478-811X-11-88
pmid: 24245560
|
|
|
| [33] |
Familtseva A, Jeremic N, Tyagi S C. Exosomes: cell-created drug delivery systems. Molecular and Cellular Biochemistry, 2019,459(1-2):1-6.
doi: 10.1007/s11010-019-03545-4
pmid: 31073888
|
|
|
| [34] |
Lv L H, Wan Y L, Lin Y, et al. Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro. The Journal of Biological Chemistry, 2012,287(19):15874-15885.
doi: 10.1074/jbc.M112.340588
pmid: 22396543
|
|
|
| [35] |
Batrakova E V, Kim M S. Using exosomes, naturally-equipped nanocarriers, for drug delivery. Journal of Controlled Release, 2015,219:396-405.
doi: 10.1016/j.jconrel.2015.07.030
pmid: 26241750
|
|
|
| [36] |
Wen Z, Mai Z, Zhu X, et al. Mesenchymal stem cell-derived exosomes ameliorate cardiomyocyte apoptosis in hypoxic conditions through microRNA144 by targeting the PTEN/AKT pathway. Stem Cell Research & Therapy, 2020,11(1):36.
doi: 10.1186/s13287-020-1563-8
pmid: 31973741
|
|
|
| [37] |
Zhang H, Bai M, Deng T, et al. Cell-derived microvesicles mediate the delivery of miR-29a/c to suppress angiogenesis in gastric carcinoma. Cancer Letters, 2016,375(2):331-339.
pmid: 27000664
|
|
|
| [38] |
Wang X, Zhang H, Bai M, et al. Exosomes serve as nanoparticles to deliver anti-miR-214 to reverse chemoresistance to cisplatin in gastric cancer. Molecular and Therapy, 2018,26(3):774-783.
|
|
|
| [39] |
Yim N, Choi C. Extracellular vesicles as novel carriers for therapeutic molecules. Bmb Reports, 2016,49(11):585-586.
doi: 10.5483/bmbrep.2016.49.11.174
pmid: 27733233
|
|
|
| [40] |
Lin Y, Wu J, Gu W, et al. Exosome-liposome hybrid nanoparticles deliver CRISPR/Cas9 system in MSCs. Advanced Science, 2018,5(4):1700611.
pmid: 29721412
|
|
|
| [41] |
Nedergaard M K, Hedegaard C J, Poulsen H S. Targeting the epidermal growth factor receptor in solid tumor malignancies. BioDrugs: Gene Therapy, 2012,26(2):83-99.
|
|
|
| [42] |
Ohno S I, Takanashi M, Sudo K, et al. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Molecular Therapy, 2013,21(1):185-191.
pmid: 23032975
|
|
|
| [43] |
Bellavia D, Raimondo S, Calabrese G, et al. Interleukin 3- receptor targeted exosomes inhibit and chronic myelogenous leukemia cell growth. Theranostics, 2017,7(5):1333-1345.
pmid: 28435469
|
|
|
| [44] |
Lou G, Chen L, Xia C, et al. MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway. Journal of Experimental & Clinical Cancer Research, 2020,39(1):4.
doi: 10.1186/s13046-019-1512-5
pmid: 31898515
|
|
|
| [45] |
Rana S, Yue S, Stadel D, et al. Toward tailored exosomes: the exosomal tetraspanin web contributes to target cell selection. The International Journal of Biochemistry & Cell Biology, 2012,44(9):1574-1584.
doi: 10.1016/j.biocel.2012.06.018
pmid: 22728313
|
|
|
| [46] |
Karjoo Z, Chen X, Hatefi A. Progress and problems with the use of suicide genes for targeted cancer therapy. Advanced Drug Delivery Reviews, 2016,99(Pt A):113-128.
doi: 10.1016/j.addr.2015.05.009
pmid: 26004498
|
|
|
| [47] |
Sekar T V, Foygel K, Ilovich O, et al. Noninvasive theranostic imaging of HSV1-sr39TK-NTR/GCV-CB1954 dual-prodrug therapy in metastatic lung lesions of MDA-MB-231 triple negative breast cancer in mice. Theranostics, 2014,4(5):460-474.
pmid: 24669276
|
|
|
| [48] |
Sekar T V, Foygel K, Willmann J K, et al. Dual-therapeutic reporter genes fusion for enhanced cancer gene therapy and imaging. Gene Therapy, 2013,20(5):529-537.
doi: 10.1038/gt.2012.66
pmid: 22914496
|
|
|
| [49] |
Kanada M, Kim B D, Hardy J W, et al. Microvesicle-mediated delivery of minicircle DNA results in effective gene-directed enzyme prodrug cancer therapy. Molecular Cancer Therapeutics, 2019,18(12):2331-2342.
doi: 10.1158/1535-7163.MCT-19-0299
pmid: 31451563
|
|
|
| [50] |
Salvati A, Pitek A S, Monopoli M P, et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nature Nanotechnology, 2013,8(2):137-143.
pmid: 23334168
|
|
|
| [51] |
Xie X, Wu H, Li M, et al. Progress in the application of exosomes as therapeutic vectors in tumor-targeted therapy. Cytotherapy, 2019,21(5):509-524.
pmid: 30686589
|
|
|
| [52] |
Sharif S, Ghahremani M H, Soleimani M. Delivery of exogenous miR-124 to glioblastoma multiform cells by Wharton’s Jelly mesenchymal stem cells decreases cell proliferation and migration, and confers chemosensitivity. Stem Cell Reviews and Reports, 2018,14(2):236-246.
doi: 10.1007/s12015-017-9788-3
pmid: 29185191
|
|
|
| [53] |
Zhao H, Yang L, Baddour J, et al. Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism. Elife, 2016,5:10250.
|
|
|
| [54] |
Yong T, Zhang X, Bie N, et al. Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy. Nature Communications, 2019,10(1):3838.
pmid: 31444335
|
|
|
| [55] |
Mashouri L, Yousefi H, Aref A R, et al. Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance. Molecular Cancer, 2019,18(1):75.
doi: 10.1186/s12943-019-0991-5
pmid: 30940145
|
|
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
